Attentional and Emotional Consequences of Emotional Acceptance and Suppression in an Elevated Anxiety Sample

Acceptance-based strategies have been incorporated into behavioral therapies for anxiety and other disorders (e.g., Roemer & Orsillo, 2009). Experimental literature is in need of better, more nuances assessment of the consequences of acceptance (Kohl, Rief & Glombiewski, 2012). Therefore, this study specifically examined the way in which acceptance can increase attentional flexibility and recovery from stress, which are important factors in the maintenance of anxiety disorders (Cisler & Koster, 2010). This experimental study compared acceptance and suppression of emotional experiences, following exposure to fearful stimuli (i.e., images and film clip), to a control condition. Results indicated that there was no significant relation between dimensional self-ratings of trait and state emotion regulation ability, trait acceptance, disengagement from viewing distressing images, and recovery from distress. Experimental analyses revealed that no emotion regulation strategy- acceptance or suppression- allowed individuals to disengage and recover from the negative images significantly more quickly. Also no emotion regulation strategy led to significantly lower levels of self-reported negative affect and higher willingness to view more distressing images. However, nonsignificant trends of medium to large effect sizes emerged, with unexpected correlational findings suggesting that trait levels of experiential avoidance and emotion regulation difficulties were associated with the ability to disengage from images, while acceptance instructions may have facilitated disengagement following the task. There were several limitations to this study. First the sample size was small limiting the ability to detect effects of the independent variable (i.e., emotion regulation instructions). Also randomization was not successful and the conditions were imbalanced on several key variables. Lastly the mood induction was not successful in inducing fear in this sample, therefore limiting the ability to comment on participants’ reaction to distress and recovery from distress. Given that there were several limitations to this study, it is important for future research to make the study alterations recommended and conduct further research on this topic

Cannabis use and neurocognitive functioning in a non-clinical sample of users

OBJECTIVE: With the recent debates over marijuana legalization and increases in use, it is critical to examine its role in cognition. While many studies generally support the adverse acute effects of cannabis on neurocognition, the non-acute effects remain less clear. The current study used a cross-sectional design to examine relationships between recent and past cannabis use on neurocognitive functioning in a non-clinical adult sample. METHOD: One hundred and fifty-eight participants were recruited through fliers distributed around local college campuses and the community. All participants completed the Brief Drug Use History Form, the Structured Clinical Interview for DSM-IV Disorders, and neurocognitive assessment, and underwent urine toxicology screening. Participants consisted of recent users (n = 68), past users (n = 41), and non-users (n = 49). RESULTS: Recent users demonstrated significantly (p < .05) worse performance than non-users across cognitive domains of attention/working memory (M = 42.4, SD = 16.1 vs. M = 50.5, SD = 10.2), information processing speed (M = 44.3, SD = 7.3 vs. M = 52.1, SD = 11.0), and executive functioning (M = 43.6, SD = 13.4 vs. M = 48.6, SD = 7.2). There were no statistically significant differences between recent users and past users on neurocognitive performance. Frequency of cannabis use in the last 4 weeks was negatively associated with global neurocognitive performance and all individual cognitive domains. Similarly, amount of daily cannabis use was negatively associated with global neurocognitive performance and individual cognitive domains. CONCLUSIONS: Our results support the widespread adverse effects of cannabis use on neurocognitive functioning. Although some of these adverse effects appear to attenuate with abstinence, past users' neurocognitive functioning was consistently lower than non-users

Cannabis use and neurocognitive functioning in a non-clinical sample of users.

ObjectiveWith the recent debates over marijuana legalization and increases in use, it is critical to examine its role in cognition. While many studies generally support the adverse acute effects of cannabis on neurocognition, the non-acute effects remain less clear. The current study used a cross-sectional design to examine relationships between recent and past cannabis use on neurocognitive functioning in a non-clinical adult sample.MethodOne hundred and fifty-eight participants were recruited through fliers distributed around local college campuses and the community. All participants completed the Brief Drug Use History Form, the Structured Clinical Interview for DSM-IV Disorders, and neurocognitive assessment, and underwent urine toxicology screening. Participants consisted of recent users (n=68), past users (n=41), and non-users (n=49).ResultsRecent users demonstrated significantly (p&lt;.05) worse performance than non-users across cognitive domains of attention/working memory (M=42.4, SD=16.1 vs. M=50.5, SD=10.2), information processing speed (M=44.3, SD=7.3 vs. M=52.1, SD=11.0), and executive functioning (M=43.6, SD=13.4 vs. M=48.6, SD=7.2). There were no statistically significant differences between recent users and past users on neurocognitive performance. Frequency of cannabis use in the last 4 weeks was negatively associated with global neurocognitive performance and all individual cognitive domains. Similarly, amount of daily cannabis use was negatively associated with global neurocognitive performance and individual cognitive domains.ConclusionsOur results support the widespread adverse effects of cannabis use on neurocognitive functioning. Although some of these adverse effects appear to attenuate with abstinence, past users' neurocognitive functioning was consistently lower than non-users

Mild test anxiety influences neurocognitive performance among African Americans and European Americans: Identifying interfering and facilitating sources.

The current study examined ethnic/racial differences in test-related anxiety and its relationship to neurocognitive performance in a community sample of African American (n = 40) and European American (n = 36) adults. The authors hypothesized the following: (a) Test-anxiety related to negative performance evaluation would be associated with lower neurocognitive performance, whereas anxiety unrelated to negative evaluation would be associated with higher neurocognitive performance. (b) African American participants would report higher levels of anxiety about negative performance evaluation than European Americans. (c) European Americans would report higher levels of anxiety unrelated to negative performance evaluation. The first two hypotheses were supported: Ethnic/racial differences in test-taking anxiety emerged such that African Americans reported significantly higher levels of negative performance evaluation, which was associated with lower cognitive performance. The third hypothesis was not supported: African Americans and European Americans reported similar levels of test-anxiety unrelated to negative evaluation